Two populations.
Two very different jobs.
Early production creates more than revenue.
These assets strengthen the broader growth system: better targeting, better scripts, better workflow, and a baseline the Proof Engine can measure against.
One week where marketing, activation, team execution, consultations and case starts operate together.
The objective isn’t a temporary spike. Each Production Week creates learning that improves the next cycle.
Don’t keep asking an unready patient to buy.
Help them become informed enough to make a decision when the time is right. The long-term nurture ecosystem meets people where they are and keeps the conversation clinically grounded.
Production today funds the market you’ll sell to next year.
Immediate production creates revenue, data and evidence. Reinvest a share into education and nurture, and the next activation cycle starts with a warmer, better-informed market.
This is a compounding system, not a sequence of isolated advertising campaigns.
Patients who aren’t ready today shouldn’t disappear into a CRM.
When clinically appropriate, existing patients can enter a structured process of education, documentation, recall and monitoring, so the conversation continues inside normal care instead of ending with “not interested.”
Explore Malocclusion Monitoring →What if malocclusion was monitored, not just mentioned?
The Malocclusion Monitoring Program gives the much larger future market a clinical pathway inside the practice.
